Company intelligence / Profile preview

Nanfang Pharmaceutical

Mingxi, Fujian, China

Ownership: Private
Employees: ~350
Development stage: Other

Overview

Nanfang Pharmaceutical is a China-based pharmaceutical company specializing in the research, development, and large-scale production of anti-tumor Active Pharmaceutical Ingredients (APIs) and intermediates. The company is particularly recognized for its expertise in taxane-based therapies, maintaining a significant global market share for products such as paclitaxel and docetaxel. Beyond its core oncology portfolio, Nanfang Pharmaceutical provides contract manufacturing (CMO) and development services (CDMO) for a variety of small molecule drugs. Its facilities are designed to meet international quality standards, including GMP certifications from the NMPA and other global regulatory bodies.

Therapeutic areas: Oncology
Modalities: Small molecule
Industry: Contract Manufacturing Organization

Beyond the preview

Go deeper on Nanfang Pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nanfang Pharmaceutical.

Explore the full profile